Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Schilke Tobin disposed of 79,427 Crinetics Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 1, 2026
On Sep 1, 2026, Schilke Tobin (Chief Financial & Infra. Ofcr.) disposed of 79,427 Crinetics Pharmaceuticals, Inc. shares at US$85.00 for US$6.75M, leaving 0 shares. Filed Sep 1, 2026 (Form 4).
- Disposed of
- 79,427 shares
- Price
- US$85.00
- Value
- US$6.75M
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Financial & Infra. Ofcr.
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Disposition | 7,956 | US$85.00 | 71,471 | Direct |
| Sep 1, 2026 | Common Stock | Disposition | 71,471 | US$85.00 | 0 | Direct |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Schilke Tobin
- Crinetics Pharmaceuticals, Inc. shareholders
- Form 4 · Schilke Tobin · Aug 24, 2026
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Fust Matthew K · Sep 1, 2026